May A Beydoun1, Angedith Poggi-Burke, Alan B Zonderman, Ola S Rostant, Michele K Evans, Deidra C Crews. 1. From the Laboratory of Epidemiology and Population Sciences (Beydoun, Poggi-Burke, Zonderman, Rostant, Evans), National Institute on Aging, National Institutes of Health; Division of Nephrology (Crews), Department of Medicine, Johns Hopkins University School of Medicine; and Welch Center for Prevention (Crews), Epidemiology and Clinical Research, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Abstract
OBJECTIVE: Perceived discrimination has been associated with psychosocial distress and adverse health outcomes. We examined associations of perceived discrimination measures with changes in kidney function in a prospective cohort study, the Healthy Aging in Neighborhoods of Diversity across the Life Span. METHODS: Our study included 1620 participants with preserved baseline kidney function (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m) (662 whites and 958 African Americans, aged 30-64 years). Self-reported perceived racial discrimination and perceived gender discrimination (PGD) and a general measure of experience of discrimination (EOD) ("medium versus low," "high versus low") were examined in relation to baseline, follow-up, and annual rate of change in eGFR using multiple mixed-effects regression (γbase, γrate) and ordinary least square models (γfollow). RESULTS: Perceived gender discrimination "high versus low PGD" was associated with a lower baseline eGFR in all models (γbase = -3.51 (1.34), p = .009 for total sample). Among white women, high EOD was associated with lower baseline eGFR, an effect that was strengthened in the full model (γbase = -5.86 [2.52], p = .020). Overall, "high versus low" PGD was associated with lower follow-up eGFR (γfollow = -3.03 [1.45], p = .036). Among African American women, both perceived racial discrimination and PGD were linked to lower follow-up kidney function, an effect that was attenuated with covariate adjustment, indicating mediation through health-related, psychosocial, and lifestyle factors. In contrast, EOD was not linked to follow-up eGFR in any of the sex by race groups. CONCLUSIONS: Perceived racial and gender discrimination are associated with lower kidney function assessed by glomerular filtration rate and the strength of associations differ by sex and race groups. Perceived discrimination deserves further investigation as a psychosocial risk factors for kidney disease.
OBJECTIVE: Perceived discrimination has been associated with psychosocial distress and adverse health outcomes. We examined associations of perceived discrimination measures with changes in kidney function in a prospective cohort study, the Healthy Aging in Neighborhoods of Diversity across the Life Span. METHODS: Our study included 1620 participants with preserved baseline kidney function (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m) (662 whites and 958 African Americans, aged 30-64 years). Self-reported perceived racial discrimination and perceived gender discrimination (PGD) and a general measure of experience of discrimination (EOD) ("medium versus low," "high versus low") were examined in relation to baseline, follow-up, and annual rate of change in eGFR using multiple mixed-effects regression (γbase, γrate) and ordinary least square models (γfollow). RESULTS: Perceived gender discrimination "high versus low PGD" was associated with a lower baseline eGFR in all models (γbase = -3.51 (1.34), p = .009 for total sample). Among white women, high EOD was associated with lower baseline eGFR, an effect that was strengthened in the full model (γbase = -5.86 [2.52], p = .020). Overall, "high versus low" PGD was associated with lower follow-up eGFR (γfollow = -3.03 [1.45], p = .036). Among African American women, both perceived racial discrimination and PGD were linked to lower follow-up kidney function, an effect that was attenuated with covariate adjustment, indicating mediation through health-related, psychosocial, and lifestyle factors. In contrast, EOD was not linked to follow-up eGFR in any of the sex by race groups. CONCLUSIONS: Perceived racial and gender discrimination are associated with lower kidney function assessed by glomerular filtration rate and the strength of associations differ by sex and race groups. Perceived discrimination deserves further investigation as a psychosocial risk factors for kidney disease.
Authors: Yendelela L Cuffee; J Lee Hargraves; Milagros Rosal; Becky A Briesacher; Antoinette Schoenthaler; Sharina Person; Sandral Hullett; Jeroan Allison Journal: Am J Public Health Date: 2013-09-12 Impact factor: 9.308
Authors: Andrew H Kemp; Julian Koenig; Julian F Thayer; Marcio S Bittencourt; Alexandre C Pereira; Itamar S Santos; Eduardo M Dantas; José G Mill; Dora Chor; Antonio L P Ribeiro; Isabela M Benseñor; Paulo A Lotufo Journal: Psychosom Med Date: 2016-10 Impact factor: 4.312
Authors: Sarah L Szanton; Joseph M Rifkind; Joy G Mohanty; Edgar R Miller; Roland J Thorpe; Eneka Nagababu; Elissa S Epel; Alan B Zonderman; Michele K Evans Journal: Int J Behav Med Date: 2012-12
Authors: May A Beydoun; Marie T Fanelli Kuczmarski; Hind A Beydoun; Joseph R Hibbeln; Michele K Evans; Alan B Zonderman Journal: J Nutr Date: 2013-09-04 Impact factor: 4.798
Authors: Amanda B Brodish; Courtney D Cogburn; Thomas E Fuller-Rowell; Stephen Peck; Oksana Malanchuk; Jacquelynne S Eccles Journal: Race Soc Probl Date: 2011-08-31
Authors: Samaah Sullivan; Muhammad Hammadah; Ibhar Al Mheid; Amit Shah; Yan V Sun; Michael Kutner; Laura Ward; Elizabeth Blackburn; Jinying Zhao; Jue Lin; J Douglas Bremner; Arshed A Quyyumi; Viola Vaccarino; Tené T Lewis Journal: Psychoneuroendocrinology Date: 2019-03-25 Impact factor: 4.905
Authors: Elizabeth J Pantesco; Daniel K Leibel; Jason J Ashe; Shari R Waldstein; Leslie I Katzel; Hans B Liu; Nan-Ping Weng; Michele K Evans; Alan B Zonderman; Danielle L Beatty Moody Journal: Psychoneuroendocrinology Date: 2018-08-12 Impact factor: 4.905
Authors: Joseph Lunyera; Clemontina A Davenport; Nrupen A Bhavsar; Mario Sims; Julia Scialla; Jane Pendergast; Rasheeda Hall; Crystal C Tyson; Jennifer St Clair Russell; Wei Wang; Adolfo Correa; L Ebony Boulware; Clarissa J Diamantidis Journal: Clin J Am Soc Nephrol Date: 2018-01-03 Impact factor: 8.237
Authors: Deidra C Crews; Tanushree Banerjee; Donald E Wesson; Hal Morgenstern; Rajiv Saran; Nilka Ríos Burrows; Desmond E Williams; Neil R Powe Journal: Am J Nephrol Date: 2018-03-09 Impact factor: 3.754
Authors: Samantha G Bromfield; Samaah Sullivan; Ryan Saelee; Lisa Elon; Bruno Lima; An Young; Irina Uphoff; Lian Li; Arshed Quyyumi; J Douglas Bremner; Viola Vaccarino; Tené T Lewis Journal: Ann Behav Med Date: 2020-10-01
Authors: Danielle L Beatty Moody; Daniel K Leibel; Elizabeth J Pantesco; Carrington R Wendell; Shari R Waldstein; Michele K Evans; Alan B Zonderman Journal: Psychosom Med Date: 2020 Feb/Mar Impact factor: 3.864